• +91 40 6608 6608
  • info@vivimedlabs.com
  • Live stock info at NSE
  • Live stock info at BSE
  • Login
VivimedlabsVivimedlabs

Welcome to Vivimedlabs

  • Home
  • About
    • About Us
    • History
    • Management
    • Board of Directors
    • Code of Conduct
  • Values
  • Business Portfolio
    • Active Pharmaceutical Ingredients
    • Finished Dosage Formulations
    • Specialty Chemicals
    • R&D
  • Awards & Achievements
  • Investors
    • Financials
    • Corporate Governance
    • Annual Reports
    • Shareholders Information
    • Other Data
  • CSR
  • News & Events
  • Contact Us
    • Careers
    • Contact Us

Lauch of Jarocol Sapphire Blue

Vivimedlabs   →  News   →  Lauch of Jarocol Sapphire Blue
09
Aug
Date August 9, 2020
Categories News

Lauch of Jarocol Sapphire Blue

Jarocol Sapphire Blue

Author sqenta

Categories

  • News 5

Recent Posts

  • Vivimed Launches its own brand of favipiravir, FavulousAugust 9, 2020
  • Appointment of the group CEO, Ramesh KrishnamurthyAugust 8, 2018
  • 2018- acquisition of Soneas, a CDMO based out of Budapest, Hungary.September 2, 2020
  • Orbimed Asia invests in UQUIFA, the API entity of Vivimed LabsSeptember 2, 2020
  • Lauch of Jarocol Sapphire BlueAugust 9, 2020

Archives

  • September 2020
  • August 2020
  • August 2018
Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated Readmore

About Us

  • About Us
  • History
  • Management
  • Board of Directors
  • Code of Conduct

Business Portfolio

  • Active Pharmaceutical Ingredients
  • Finished Dosage Formulations
  • Specialty Chemicals
  • R&D

Investors

  • Financials
  • Corporate Governance
  • Annual Reports
  • Shareholders Information
  • Other Data
© Copyright 2016-2020. All Rights Reserved

Powered by Sqenta